Published in:
01-12-2020 | Acute Kidney Injury | Research Letter
Metformin use and early lactate levels in critically ill patients according to chronic and acute renal impairment
Authors:
Rene A. Posma, Adam Hulman, Reimar W. Thomsen, Bente Jespersen, Maarten W. Nijsten, Christian F. Christiansen
Published in:
Critical Care
|
Issue 1/2020
Login to get access
Excerpt
Metformin is the most widely used oral antihyperglycemic agent. Because it is eliminated unmodified in urine, patients with renal insufficiency can accumulate metformin and may develop lactic acidosis [
1]. Recent guidelines only restrict the use of metformin in patients with severe chronic kidney disease (CKD) because the benefit is considered larger than the risk for lactic acidosis [
2]. Lactate measurement has a central role in identifying and monitoring critical illness [
3]. A better understanding of the impact of metformin on lactate levels could improve clinical assessment of the critically ill. …